Management and prognosis of pancreatic cancer over a 30-year period
Open Access
- 30 June 2009
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 101 (2) , 215-218
- https://doi.org/10.1038/sj.bjc.6605150
Abstract
BACKGROUND: The aim of this study was to report on changes in the diagnostic assessment, patterns of care and survival over time for pancreatic cancers. METHODS: A total of 2986 cases of pancreatic cancer from the Digestive Cancer Registry of Burgundy (France) over a 30-year period (1976–2005) were considered. Non-conditional logistic regressions were carried out to identify the factors associated with resection for cure and with the use of chemotherapy. A multivariate relative survival analysis was carried out. RESULTS: Diagnostic procedures have changed. Ultrasonography and computed tomography progressively have become the major diagnostic procedures. There was a slight improvement in stage: the proportion of stage I–II was 2.8% in the 1976–1980 period and 8.8% in the 2001–2005 period (PPP<0.001). In the multivariate relative survival analysis, the period remained a significant prognostic factor. Stage, sex, age and histology were independent prognostic factors. CONCLUSION: Over a 30-year period, there were minor changes in the stage at diagnosis, resection for cure and prognosis of pancreatic cancers, although there were improvements in the diagnostic modalities. Pancreatic cancer still represents a major challenge in oncology.Keywords
This publication has 8 references indexed in Scilit:
- Survival from cancer of the pancreas in England and Wales up to 2001British Journal of Cancer, 2008
- Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analysesBritish Journal of Cancer, 2008
- National Failure to Operate on Early Stage Pancreatic CancerAnnals of Surgery, 2007
- Prognostic factors for survival in pancreatic cancer: a population-based studyThe American Journal of Surgery, 2006
- Differences in Survival by Histologic Type of Pancreatic CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Meta-analysis of randomised adjuvant therapy trials for pancreatic cancerBritish Journal of Cancer, 2005
- Incidence and management of malignant digestive endocrine tumours in a well defined French populationGut, 2004
- EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentaryAnnals of Oncology, 2003